OpenDx - Universal Access to Disease Diagnostics

Bridging the Diagnostic Gap

Our four-pronged approach to transforming public health diagnostics

We Work With Innovators & Funders

OpenDx engages with innovators and funders to identify solutions that can fill critical market gaps in diagnostic innovation. We help connect breakthrough technologies with the resources needed to scale and validate them, supporting funders in their evaluation decisions.

Identify market gaps in diagnostic innovation
Support funders in evaluating promising innovations
Facilitate ecosystem connections and partnerships
Enable evidence-based investment decisions

Field Validation & Hand-Holding Support

We provide hands-on support to innovators for public health field validation and evidence generation. Through partnerships with implementing organizations like KNCV, IIH, and other agencies running field programs, we ensure innovations are tested and validated in real-world settings at various stages of product development lifecycle.

Coordinate with field implementation agencies (IIH, KNCV, etc.)
Design and execute validation studies at multiple product development stages
Collect critical feedback from end-users and practitioners
Generate real-world evidence for regulatory and deployment pathways

Building the Diagnostic Ecosystem

OpenDx acts as a connector, bringing together NGOs, implementing agencies, innovators, and funders. We create the infrastructure and partnerships needed for sustainable innovation at scale in public health.

Engage implementing NGOs and government agencies
Facilitate knowledge sharing and learnings across partners
Build sustainable implementation networks
Enable long-term partnerships for lasting impact

Open-Source AI Models for Public Health

We develop and maintain open-source AI models for critical disease areas including TB detection, HPV testing, diabetic retinopathy, and cervical cancer screening. These models democratize access to diagnostic intelligence globally, enabling implementation in resource-constrained settings.

Build robust, rigorously validated AI models for public health
Ensure accessibility through open-source licensing
Enable implementation in low-resource and remote settings
Drive continuous improvement through community contributions

Our NorthStars

Ambitious targets driving innovation and accessibility in global health diagnostics

MTB + 1st Line Drug Resistance

Rapid TB diagnosis with resistance profiling

1¢

AI-Powered X-ray Scans

Ultra-affordable automated image analysis

HPV-16/18 Testing

Cervical cancer prevention screening

HPV 14-Gene Test

Comprehensive high-risk genotyping

<$7.5K

Affordable X-ray Machines

Accessible imaging for remote clinics

More NorthStars

Expanding impact across disease areas

Accelerating Universal Access